Perspective: cancer vaccines in the era of immune checkpoint blockade

von Cebon, Jonathan
Veröffentlicht in Mamm Genome (2018)

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy

von Parakh, Sagun, Cebon, Jonathan, Klein, Oliver
Veröffentlicht in Oncologist (2018)

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

von Gunjur, Ashray, Klein, Oliver, Kee, Damien, Cebon, Jonathan
Veröffentlicht in J Immunother Cancer (2019)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells

von Woods, Katherine, Pasam, Anupama, Jayachandran, Aparna, Andrews, Miles C., Cebon, Jonathan
Veröffentlicht in Front Oncol (2014)

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells

von Jayachandran, Aparna, McKeown, Sonja J., Woods, Briannyn L., Prithviraj, Prashanth, Cebon, Jonathan
Veröffentlicht in Front Oncol (2015)

A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases

von Arulananda, Surein, Parakh, Sagun, Palmer, Jodie, Goodwin, Mark, Andrews, Miles C., Cebon, Jonathan
Veröffentlicht in Cancer Rep (Hoboken) (2019)

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations

von Vella, Laura J, Andrews, Miles C, Pasam, Anupama, Woods, Katherine, Behren, Andreas, Cebon, Jonathan S
Veröffentlicht in Oncoimmunology (2014)

Characterising the phenotypic evolution of circulating tumour cells during treatment

von Tsao, Simon Chang-Hao, Wang, Jing, Wang, Yuling, Behren, Andreas, Cebon, Jonathan, Trau, Matt
Veröffentlicht in Nat Commun (2018)

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ()

von Vella, Laura J., Behren, Andreas, Coleman, Bradley, Greening, David W., Hill, Andrew F., Cebon, Jonathan
Veröffentlicht in Neoplasia (2017)

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

von Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Veröffentlicht 2012

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma

von Parker, Robert, Vella, Laura J., Xavier, Dylan, Amirkhani, Ardeshir, Parker, Jimmy, Cebon, Jonathan, Molloy, Mark P.
Veröffentlicht in Front Oncol (2015)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

von Chang-Hao Tsao, Simon, Weiss, Jonathan, Hudson, Christopher, Christophi, Christopher, Cebon, Jonathan, Behren, Andreas, Dobrovic, Alexander
Veröffentlicht in Sci Rep (2015)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma

von Woods, Katherine, Knights, Ashley J., Anaka, Matthew, Schittenhelm, Ralf B., Purcell, Anthony W., Behren, Andreas, Cebon, Jonathan
Veröffentlicht in J Immunother Cancer (2016)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma

von Andrews, Miles C., Cursons, Joseph, Hurley, Daniel G., Anaka, Matthew, Cebon, Jonathan S., Behren, Andreas, Crampin, Edmund J.
Veröffentlicht in Mol Cancer (2016)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

von Tutuka, Candani S. A., Andrews, Miles C., Mariadason, John M., Ioannidis, Paul, Hudson, Christopher, Cebon, Jonathan, Behren, Andreas
Veröffentlicht in Mol Cancer (2017)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

von Prithviraj, Prashanth, Anaka, Matthew, McKeown, Sonja J, Permezel, Michael, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas, Jayachandran, Aparna
Veröffentlicht in Oncotarget (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer

von Woods, Katherine, Schittenhelm, Ralf B, Heesterbeek, Dani, Knights, Ashley, Anaka, Matthew, Purcell, Anthony W, Behren, Andreas, Cebon, Jonathan
Veröffentlicht in J Immunother Cancer (2015)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

von Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Veröffentlicht in J Immunother Cancer (2015)

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

von Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Veröffentlicht in BMC Nephrol (2020)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

von Anaka, Matthew, Hudson, Christopher, Lo, Pu-Han, Do, Hongdo, Caballero, Otavia L, Davis, Ian D, Dobrovic, Alexander, Cebon, Jonathan, Behren, Andreas
Veröffentlicht 2013